AARD
Aardvark Therapeutics, Inc.Company with tickers: AARD
CIK
1774857
CUSIP
002942100
Shares Outstanding
21,816,385
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-02-09 | Sun Nelson | Chief Financial Officer | Award | 70,549 |
| 2026-02-09 | Jaiman Manasi | Chief Medical Officer | Award | 70,549 |
| 2026-02-09 | Lee Tien-Li | Director, Chief Executive Officer, 10% Owner | Award | 203,851 |
| 2025-12-11 | Sun Nelson | Chief Financial Officer | Buy | 3,000 |
| 2025-12-11 | Lee Tien-Li | Director, Chief Executive Officer, 10% Owner | Buy | 7,000 |
| 2025-12-11 | Lee Tien-Li | Director, Chief Executive Officer, 10% Owner | Other | 1,474,028 |
| 2025-10-15 | Jones Bryan | Chief Operating Officer | Convert | 1,250 |
| 2025-10-15 | Jones Bryan | Chief Operating Officer | Convert | 1,250 |
| 2025-10-15 | Lee Tien-Li | Director, Chief Executive Officer, 10% Owner | Other | 1,474,028 |
| 2025-10-15 | Lee Tien-Li | Director, Chief Executive Officer, 10% Owner | Convert | 1,229 |
| 2025-10-15 | Lee Tien-Li | Director, Chief Executive Officer, 10% Owner | Convert | 1,229 |
| 2025-09-15 | Lee Tien-Li | Director, Chief Executive Officer, 10% Owner | Other | 1,474,028 |
| 2025-09-15 | Lee Tien-Li | Director, Chief Executive Officer, 10% Owner | Buy | 6,500 |
| 2025-09-15 | Lee Tien-Li | Director, Chief Executive Officer, 10% Owner | Buy | 3,500 |
| 2025-09-12 | Lee Tien-Li | Director, Chief Executive Officer, 10% Owner | Buy | 5,000 |
| 2025-09-11 | Lee Tien-Li | Director, Chief Executive Officer, 10% Owner | Buy | 6,000 |
| 2025-09-10 | Lee Tien-Li | Director, Chief Executive Officer, 10% Owner | Buy | 9,000 |
| 2025-09-10 | Lee Tien-Li | Director, Chief Executive Officer, 10% Owner | Other | 1,474,028 |
| 2025-09-09 | Sun Nelson | Chief Financial Officer | Buy | 6,000 |
| 2025-08-28 | Lee Tien-Li | Director, Chief Executive Officer, 10% Owner | Other | 1,474,028 |
| 2025-08-28 | Lee Tien-Li | Director, Chief Executive Officer, 10% Owner | Convert | 17,209 |
| 2025-08-28 | Lee Tien-Li | Director, Chief Executive Officer, 10% Owner | Convert | 17,209 |
| 2025-06-11 | Lee Tien-Li | Director, Chief Executive Officer, 10% Owner | Award | 549,534 |
| 2025-06-11 | Chi Jeffrey | Director | Award | 61,017 |
| 2025-06-11 | Jaiman Manasi | Chief Medical Officer | Award | 126,999 |
| 2025-06-11 | Graf Susan E | Director | Award | 30,508 |
| 2025-06-11 | Tong Victor Edward Jr | Director | Award | 61,017 |
| 2025-06-11 | Sun Nelson | Chief Financial Officer | Award | 209,826 |
| 2025-06-11 | Jones Bryan | Chief Operating Officer | Award | 122,033 |
| 2025-06-11 | Baynes Roy D. | Chief Medical Officer | Award | 30,508 |
| 2025-02-14 | Lee Tien-Li | Director, Chief Executive Officer, 10% Owner | Buy | 16,542 |
| 2025-02-14 | Lee Tien-Li | Director, Chief Executive Officer, 10% Owner | Other | 1,474,028 |
| 2025-02-14 | Lee Tien-Li | Director, Chief Executive Officer, 10% Owner | Other | 350,002 |
| 2025-02-14 | Lee Tien-Li | Director, Chief Executive Officer, 10% Owner | Other | 41,303 |
| 2025-02-14 | Sun Nelson | Chief Financial Officer | Other | 7,001 |
| 2025-02-14 | Sun Nelson | Chief Financial Officer | Other | 59,332 |
| 2025-02-14 | Sun Nelson | Chief Financial Officer | Buy | 10,000 |
| 2025-02-14 | Cormorant Asset Management, LP | Insider | Other | 800,189 |
| 2025-02-14 | Cormorant Asset Management, LP | Insider | Buy | 187,500 |
| 2025-02-14 | Cormorant Asset Management, LP | Insider | Other | 6,780,810 |
| 2025-02-14 | Decheng Capital Global Life Sciences Fund IV, L.P. | 10% Owner | Other | 2,333,887 |
| 2025-02-14 | Decheng Capital Global Life Sciences Fund IV, L.P. | 10% Owner | Other | 2,825,337 |
| 2025-02-14 | Decheng Capital Global Life Sciences Fund IV, L.P. | 10% Owner | Other | 333,412 |
| 2025-02-14 | Decheng Capital Global Life Sciences Fund IV, L.P. | 10% Owner | Other | 19,777,363 |
| 2025-02-14 | Decheng Capital Global Life Sciences Fund IV, L.P. | 10% Owner | Buy | 625,000 |
| 2025-02-14 | Decheng Capital Global Life Sciences Fund IV, L.P. | 10% Owner | Buy | 625,000 |
| 2025-02-14 | Chi Jeffrey | Director | Other | 1,130,135 |
| 2025-02-14 | Chi Jeffrey | Director | Other | 133,364 |
| 2025-02-14 | Vickers Venture Fund VI Pte Ltd | 10% Owner | Other | 1,637,411 |
| 2025-02-14 | Vickers Venture Fund VI Pte Ltd | 10% Owner | Other | 13,875,429 |
| 2025-02-14 | Vickers Venture Fund VI Pte Ltd | 10% Owner | Other | 413,491 |
| 2025-02-14 | Vickers Venture Fund VI Pte Ltd | 10% Owner | Other | 3,503,919 |
| 2025-02-12 | Baynes Roy D. | Chief Medical Officer | Other | 0 |
| 2025-02-12 | Jaiman Manasi | Chief Medical Officer | Other | 0 |
| 2025-02-12 | Chi Jeffrey | Director | Other | 0 |
| 2025-02-12 | Lee Tien-Li | Director, Chief Executive Officer, 10% Owner | Other | 0 |
| 2025-02-12 | Lee Tien-Li | Director, Chief Executive Officer, 10% Owner | Other | 0 |
| 2025-02-12 | Lee Tien-Li | Director, Chief Executive Officer, 10% Owner | Other | 1,474,028 |
| 2025-02-12 | Lee Tien-Li | Director, Chief Executive Officer, 10% Owner | Other | 1,438,330 |
| 2025-02-12 | Decheng Capital Global Life Sciences Fund IV, L.P. | 10% Owner | Other | 0 |
| 2025-02-12 | Decheng Capital Global Life Sciences Fund IV, L.P. | 10% Owner | Other | 0 |
| 2025-02-12 | Jones Bryan | Chief Operating Officer | Other | 0 |
| 2025-02-12 | Jones Bryan | Chief Operating Officer | Other | 0 |
| 2025-02-12 | Jones Bryan | Chief Operating Officer | Other | 0 |
| 2025-02-12 | Jones Bryan | Chief Operating Officer | Other | 0 |
| 2025-02-12 | Sun Nelson | Chief Financial Officer | Other | 82,483 |
| 2025-02-12 | Sun Nelson | Chief Financial Officer | Other | 0 |
| 2025-02-12 | Sun Nelson | Chief Financial Officer | Other | 0 |
| 2025-02-12 | Tong Victor Edward Jr | Director | Other | 0 |
| 2025-02-12 | Graf Susan E | Director | Other | 0 |
| 2025-02-12 | Vickers Venture Fund VI Pte Ltd | 10% Owner | Other | 0 |
| 2025-02-12 | Vickers Venture Fund VI Pte Ltd | 10% Owner | Other | 0 |
| 2025-02-12 | Cormorant Asset Management, LP | Insider | Other | 0 |